Top by categoryEvery category ranked by need: services, software and firms.
Top software by featureThe best tools for one job, across every software category.
Top companies by countryThe leading B2B firms in each country, category by category.
Popular software rankings
Top Inventory Management Software
Top Supplier Management Software
Top Fleet Management Software
Top Cloud Storage Backup Software
Top Master Data Management Software
Top Document Storage Software
Top 3D Modeling Software
Top Compliance Tracking Software
See all popular software rankings
Popular category rankings
Top Software Development Companies
Top Digital Marketing Companies
Top App Development Companies
Top Web Design Agencies
Top Accounting Firms
Top Recruitment Agencies
Top Advertising Companies
Top Design Agencies
See all popular category rankings
Top companies by country
Top companies in the UK
Top companies in the USA
Top companies in India
Top companies in Canada
Top companies in Australia
Top companies in Germany
Top companies in the UAE
Top companies in Pakistan
See all top companies by country
All rankings All categories How we rank

Investor

The Longevity Fund

Seed and Series A investor backing biotech founders working on ageing and age-related disease

Visit Website Get introducedRequest an introduction Write a Review

Own this listing? Claim it

The Longevity Fund cover

About The Longevity Fund

The Longevity Fund is a venture investor in companies developing drugs for ageing and the diseases that come with it. It holds that lifespan can be altered and wants new treatments to reach patients safely and quickly. Laura Deming is its founder and general partner, and Celine Halioua is a venture partner.

What The Longevity Fund offers

Seed and Series A investment — early funding for age-related drug developers.
Lead or follow roles — it can lead a round or join one led by others.
Founder support — help for the next generation of biotech founders.

Who it works with

Biotech entrepreneurs. Companies it names include ALX Oncology, Loyal, Decibel Therapeutics, Epirium Bio, Fauna Bio, Gordian Biotechnology, Metacrine, Navitor Pharmaceuticals, Precision Biosciences, Spring Discovery, System1 Biosciences and Unity Biotechnology. It reports five stock market listings among them.

Key facts

Stages: Seed and Series A
Focus: Therapeutics for ageing and age-related disease

Profile written by TrustList from the business's own published information, Oct 2026.

Ask TrustList to introduce you to The Longevity Fund

Reviews

Write the first review of The Longevity Fund

Used it? Your experience helps other buyers decide.

Questions & answers

No questions yet. Be the first to ask about The Longevity Fund.

The Longevity Fund alternatives

Similar listings buyers compare against this one.

Compare side by side

REACH

Chicago-based accelerator for technology companies serving the real estate industry

Compare

Applied Materials

Semiconductor and display equipment maker that also invests in startups through venture and research programmes

Compare

Analog Devices

Semiconductor and sensing company selling components and design tools to engineers in industrial, automotive and healthcare markets

Compare

Coinbase Ventures

Venture arm of a crypto exchange investing in early-stage web3 and blockchain startups

Compare

Insight Partners

Global software investor backing growth-stage technology companies with capital and in-house operating specialists

Compare

Alsop Louie Partners

San Francisco early-stage technology venture firm led by two founding partners with a stated humane-technology outlook

Compare

Keep exploring

More on TrustList

Everything here links back to the same verified catalogue. Pick your next stop.